申请人:Development Finance Corporation of New Zealand
公开号:US04603125A1
公开(公告)日:1986-07-29
Compounds represented by the general formula (I): ##STR1## in which R.sub.1 represents ##STR2## A and B each represent H or a lower alkane optionally substituted with amino and/or hydroxyl functions, except that A and B are not both H; R.sub.3 represents H, OCH.sub.3, CH.sub.3, halogen, NH.sub.2, NO.sub.2, NHCH.sub.3, N.sub.3 (CH.sub.3).sub.2, N.sub.3, NHCOCH.sub.3, NHCOOCH.sub.3, N(CH.sub.3)COOCH.sub.3, CONH.sub.2 or CONHCH.sub.3 ; R.sub.4 represents H, alkyl, O-alkyl, CONH.sub.2, CONHCH.sub.3 or CONHCH.sub.2 CONHCH.sub.3, except that R.sub.3 and R.sub.4 taken together can represent --C.dbd.CH--CH.dbd.N--; R.sub.5 represents H, alkyl, O-alkyl, CONH.sub.2, CONHCH.sub.3 or CONH.sub.2 CH.sub.2 CONHCH.sub.3 ; R.sub.6 represents lower alkyl; R.sub.7 represents CH.sub.3 or C.sub.6 H.sub.5 (phenyl); R.sub.8 represents lower alkyl or C.sub.6 H.sub.5 (phenyl); R.sub.9 represents H, NHCOCH.sub.3, NH.sub.2 or N.dbd.CHN(CH.sub.3).sub.2 ; and R.sub.10 represents H or NH.sub.2 ; and the acid addition salts thereof, possess antibacterial and antitumour properties.
通式(I)所代表的化合物:##STR1## 其中R.sub.1代表##STR2## A和B分别代表H或较低的烷基,可选地取代
氨基和/或羟基功能,但A和B不能同时为H;R.sub.3代表H、OCH.sub.3、CH.sub.3、卤素、NH.sub.2、NO.sub.2、NHCH.sub.3、N.sub.3(CH.sub.3).sub.2、N.sub.3、NHCOCH.sub.3、NHCOOCH.sub.3、N(CH.sub.3)COOCH.sub.3、CONH.sub.2或CONHCH.sub.3;R.sub.4代表H、烷基、O-烷基、CONH.sub.2、CONHCH.sub.3或CONHCH.sub.2 CONHCH.sub.3,但R.sub.3和R.sub.4结合在一起可以代表--C.dbd.CH--CH.dbd.N--;R.sub.5代表H、烷基、O-烷基、CONH.sub.2、CONHCH.sub.3或CONH.sub.2 CH.sub.2 CONHCH.sub.3;R.sub.6代表较低的烷基;R.sub.7代表CH.sub.3或C.sub.6 H.sub.5(苯基);R.sub.8代表较低的烷基或C.sub.6 H.sub.5(苯基);R.sub.9代表H、NHCOCH.sub.3、NH.sub.2或N.dbd.CHN(CH.sub.3).sub.2;R.sub.10代表H或NH.sub.2;以及它们的酸加成盐具有抗菌和抗肿瘤性能。